scholarly article | Q13442814 |
P356 | DOI | 10.1097/MLR.0000000000000330 |
P8608 | Fatcat ID | release_uwrstgasnjh65gfid6as5qbi7u |
P932 | PMC publication ID | 4379114 |
P698 | PubMed publication ID | 25749656 |
P50 | author | Tony Blakely | Q57449785 |
Nick Wilson | Q90100179 | ||
Giorgi Kvizhinadze | Q91141350 | ||
Philip Clarke | Q38590660 | ||
P2093 | author name string | June Atkinson | |
Anna Davies | |||
P2860 | cites work | The burden of cancer in New Zealand: a comparison of incidence and DALY metrics and its relevance for ethnic disparities | Q45852792 |
Regression models for relative survival | Q47296894 | ||
Economic evaluation and the postponement of health care costs. | Q50549440 | ||
Measuring cancer survival in populations: relative survival vs cancer-specific survival | Q53064419 | ||
Advancing the science of health care costing | Q84080708 | ||
Bending the Cost Curve in Cancer Care | Q22248106 | ||
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
Dietary patterns and breast cancer risk: a systematic review and meta-analysis | Q28275629 | ||
Estimating health care costs related to cancer treatment from SEER-Medicare data | Q33184145 | ||
The burden of illness of cancer: economic cost and quality of life | Q34198603 | ||
Cost of care for cancer in a health maintenance organization | Q34326216 | ||
Projections of the cost of cancer care in the United States: 2010-2020. | Q35022830 | ||
The high cost of cancer drugs and what we can do about it. | Q36512856 | ||
Costs of cancer care in the USA: a descriptive review. | Q36983668 | ||
Overview of methods to estimate the medical costs of cancer | Q37286387 | ||
Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries | Q38001667 | ||
Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer | Q38045810 | ||
Technology assessment for new oncology drugs | Q38071548 | ||
Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure | Q39194603 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 302-309 | |
P577 | publication date | 2015-04-01 | |
P1433 | published in | Medical Care | Q15762119 |
P1476 | title | Patterns of cancer care costs in a country with detailed individual data | |
P478 | volume | 53 |
Q58088055 | CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients |
Q31075231 | Cost of care for cancer patients in England: evidence from population-based patient-level data |
Q64114928 | Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015 |
Q36157299 | Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review. |
Q58008153 | Health services costs for cancer care in Australia: Estimates from the 45 and Up Study |
Q99633783 | Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study |
Q60917867 | Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand |
Q99710676 | Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis |
Q94399447 | Patterns of Cancer Costs in a Country With Detailed Individual Data: Erratum |
Q36166899 | Phase-specific and lifetime costs of cancer care in Ontario, Canada |
Q35835158 | Realising the Value of Linked Data to Health Economic Analyses of Cancer Care: A Case Study of Cancer 2015. |
Search more.